Global Pharmaceutical CDMO Market Analysis Report 2024-2030: AI-Assisted Drug Active Pharmaceutical Ingredient (API) Synthesis Gaining Attention
April 08, 2024 10:26 ET
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical CDMO Market Size, Share & Trends Analysis Report by Product (API, Drug Product), Workflow (Clinical, Commercial),...
Global Active Pharmaceutical Ingredient CDMO Market Projected to Reach USD 164.5 Billion by 2030
March 29, 2024 05:36 ET
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product, By Synthesis, By Drug, By Application, By Workflow,...
Global Highly Potent API (Active Pharmaceutical Ingredient) Industry Research 2023-2033: Growing Emphasis on Personalized Medicine & Increasing Opportunities for Pharma Companies in Developing Markets
March 29, 2024 05:02 ET
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Highly Potent API Market - A Global and Regional Analysis: Focus on Type, Type of Synthesis, Therapeutic Area, Type of Manufacturing, End User, and...
Global Antibody Contract Manufacturing Market Report 2023 with Profiles of Leading Players AbbVie, Samsung Biologics, Aenova, Cambrex, Eurofins Scientific, AGC Biologics and More
November 30, 2023 04:03 ET
|
Research and Markets
Dublin, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Contract Manufacturing Market 2023" report has been added to ResearchAndMarkets.com's offering.The global antibody contract...
Global Active Pharmaceutical Ingredient CDMO Market to Reach $156.3 Billion by 2030, Driven by Rising R&D Investments and Demand for Generic Drugs
November 10, 2023 08:03 ET
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product (Highly Potent API, Antibody Drug Conjugate), By...
Advancing Beyond Antibody Drug Conjugates: Next Generation Drug Conjugates Emerge as Clinical Efficacy and Stability Game Changers
October 12, 2023 05:38 ET
|
Research and Markets
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "Next Generation Drug Conjugates Market: Distribution by Type of Targeting Ligand, Type of Payload, Type of Therapy, Route of Administration, Target...
Global High Potency Active Pharmaceutical Ingredients Market Report 2023: Sector is Expected to Reach $40.66 Billion by 2030 at a CAGR of 6.2%
June 08, 2023 06:43 ET
|
Research and Markets
Dublin, June 08, 2023 (GLOBE NEWSWIRE) -- The "High Potency Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Product (Synthetic, Biotech), By Manufacturer Type...
Global Digital Biomanufacturing Market Report 2023: Growing Number of Biologics-related Clinical Trials Fuels the Sector
May 01, 2023 04:58 ET
|
Research and Markets
Dublin, May 01, 2023 (GLOBE NEWSWIRE) -- The "Digital Biomanufacturing Market - Distribution by Type of Technology, Deployment Options, Types of Biologics Manufactured, and Key Geographical Regions:...
2022 Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics Sales Report
March 30, 2023 12:18 ET
|
Research and Markets
Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics" report has been added to ResearchAndMarkets.com's...
Large Molecule Drug Substance CDMO Global Market to 2030: Increasing Large Molecule Drug Approvals Drives Growth
March 20, 2023 11:48 ET
|
Research and Markets
Dublin, March 20, 2023 (GLOBE NEWSWIRE) -- The "Large Molecule Drug Substance CDMO Market Size, Share & Trends Analysis Report By Service (Contract Manufacturing, Contract Development), By...